SAN DIEGO, Aug. 31, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) today announced that it has entered into a cooperative marketing agreement with Abbott Medical Optics Inc.'s ...

If you are looking to invest in TearLab Corporation’s (NASDAQ:TEAR), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of your ...

TearLab Corp (NASDAQ: TEAR) announced on Thursday that it had inked a co-promotion agreement with Physician Recommended Nutriceuticals (PRN), a privately-held eye health company. Under the arrangement ...

ESCONDIDO, Calif., May 11, 2020 /PRNewswire/ -- TearLab Corporation (OTCQB: TEAR), a leader in Ocular Surface Diagnostics, today announced it has entered into a definitive agreement pursuant to which ...

Please provide your email address to receive an email when new articles are posted on . Boy, what a long road TearLab has traveled. It seems like I’ve been talking to them and about them forever.

Accelmed Partners has acquired TearLab, a provider of diagnostics for dry eye disease. No financial terms were disclosed. ESCONDIDO, Calif., July 9, 2020 /PRNewswire/ — TearLab Corporation (TearLab), ...

SAN DIEGO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has determined that the ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — TearLab Corporation has partnered with COLA, a clinical laboratory accreditation organization, to ...

SAN DIEGO, Nov. 11, 2010 (GLOBE NEWSWIRE) -- TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) today reported its consolidated financial results for the quarter ended September 30, 2010. All dollar amounts ...

TearLab is looking to widen its capital base by more than $32 million in an underwritten public offering of its common stock. The company is floating 2.6 million shares at a price of $13.50 apiece.

A search of the Medicines and Healthcare Products Regulatory Agency website revealed no manufacturer Field Safety Notices or Medical Device Alerts for this device. No reports of adverse events were ...